WK175

Known as: WK 175

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2010

2010

A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Huei-Jiun Yang, Meng-Chi Yen, +6 authors M. N. Lai
Experimental biology and medicine
2010

Many types of malignant cells have a higher nicotinamide adenine dinucleotide (NAD) turnover rate than normal cells, as well as… (More)

Is this relevant?

2002

2002

WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.

Katja Wosikowski, Karin A. Mattern, Isabel Schemainda, Max Hasmann, Benno Rattel, R. Loeser
Cancer research
2002

We recently developed a class of novel antitumor agents that elicit a potent growth-inhibitory response in many tumor cells… (More)

Is this relevant?